+Compare
CGEN
Stock ticker:
NASDAQ
AS OF
Jul 1 closing price
Price
$1.92
Change
+$0.07 (+3.78%)
Capitalization
153.77M

CGEN Price Prediction, Compugen Ltd AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Jul 01, 2022

CGEN saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for CGEN moved out of overbought territory on June 28, 2022. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 51 similar instances where the indicator exited the overbought zone. In 49 of the 51 cases the stock moved lower. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

CGEN moved below its 50-day moving average on June 27, 2022 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CGEN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CGEN broke above its upper Bollinger Band on June 23, 2022. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CGEN entered a downward trend on June 22, 2022. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CGEN's RSI Oscillator exited the oversold zone, of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 21, 2022. You may want to consider a long position or call options on CGEN as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CGEN advanced for three days, in of 260 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.691) is normal, around the industry mean (24.351). P/E Ratio (0.000) is within average values for comparable stocks, (94.483). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.898). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (27.174) is also within normal values, averaging (309.271).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CGEN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CGEN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

CGEN is expected to report earnings to rise 15.55% to -12 cents per share on August 03

Compugen Ltd CGEN Stock Earnings Reports
Q2'22
Est.
$-0.13
Q1'22
Beat
by $0.02
Q4'21
Beat
by $0.03
Q3'21
Beat
by $0.05
Q2'21
Beat
by $0.01
The last earnings report on May 16 showed earnings per share of -10 cents, beating the estimate of -12 cents. With 559.58K shares outstanding, the current market capitalization sits at 153.77M.
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Global Blood Therapeutics (NASDAQ:GBT), BioCryst Pharmaceuticals (NASDAQ:BCRX), Adaptive Biotechnologies Corp (NASDAQ:ADPT).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 1.72B. The market cap for tickers in the group ranges from 2.5K to 250.31B. NONOF holds the highest valuation in this group at 250.31B. The lowest valued company is IMUND at 2.5K.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was -0%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was -36%. EVFM experienced the highest price growth at 145%, while PCNTD experienced the biggest fall at -81%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -76%. For the same stocks of the Industry, the average monthly volume growth was -46% and the average quarterly volume growth was -63%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 85
Price Growth Rating: 61
SMR Rating: 93
Profit Risk Rating: 94
Seasonality Score: -17 (-100 ... +100)
AI

View a ticker or compare two or three

AI
A.I. Advisor
published General Information

General Information

a maker of drug and diagnostics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
26 Harokmim Street
Phone
+972 37658585
Employees
51
Web
https://www.cgen.com

Interesting Tickers

1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARRRX13.76N/A
N/A
AB Global Real Estate Investment R
GSATX32.17N/A
N/A
Goldman Sachs Small Cp Val Insghts A
HSWFX14.01N/A
N/A
Hartford Schroders International Stk F
HNCUX13.41N/A
N/A
Hartford International Growth R6
UIVQX8.47N/A
N/A
MFS Intrinsic Value R4

CGEN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEN has been loosely correlated with SGMO. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if CGEN jumps, then SGMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEN
1D Price
Change %
CGEN100%
+3.78%
SGMO - CGEN
65%
Loosely correlated
+3.38%
ADPT - CGEN
64%
Loosely correlated
+4.08%
VCYT - CGEN
63%
Loosely correlated
+6.03%
VBIV - CGEN
63%
Loosely correlated
-0.01%
BEAM - CGEN
62%
Loosely correlated
+2.79%
More